Search details
1.
Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients.
Br J Haematol
; 204(1): 240-249, 2024 01.
Article
in English
| MEDLINE | ID: mdl-38062779
2.
Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
Hematol Oncol
; 42(3): e3280, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38741354
3.
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR).
Br J Haematol
; 202(1): 40-47, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36971061
4.
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options.
Blood
; 138(25): 2670-2685, 2021 12 23.
Article
in English
| MEDLINE | ID: mdl-33945616
5.
FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia.
Blood
; 138(9): 758-772, 2021 09 02.
Article
in English
| MEDLINE | ID: mdl-33786575
6.
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group.
Ann Hematol
; 102(4): 811-817, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36847805
7.
Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes.
BMC Cancer
; 22(1): 137, 2022 Feb 03.
Article
in English
| MEDLINE | ID: mdl-35114947
8.
Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group.
Hematol Oncol
; 38(4): 509-516, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32400885
9.
Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia.
Ann Hematol
; 98(12): 2749-2760, 2019 Dec.
Article
in English
| MEDLINE | ID: mdl-31745601
10.
IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisib.
Haematologica
; 106(11): 2995-2999, 2021 11 01.
Article
in English
| MEDLINE | ID: mdl-34196167
11.
Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study.
Am J Hematol
; 90(5): 417-21, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25645263
12.
The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab.
Eur J Haematol
; 90(6): 479-85, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23506191
13.
Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations.
Front Oncol
; 12: 859618, 2022.
Article
in English
| MEDLINE | ID: mdl-35814434
14.
Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of WNT5A promoter and undetectable expression of WNT5A gene.
Epigenetics
; 17(12): 1628-1635, 2022 12.
Article
in English
| MEDLINE | ID: mdl-35333703
15.
Rituximab induces rapid blood repopulation by CLL cells mediated through their release from immune niches and complement exhaustion.
Leuk Res
; 111: 106684, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34438120
16.
LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies.
J Mol Diagn
; 23(8): 959-974, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34082072
17.
Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia - Czech national study.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
; 164(4): 425-434, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-31558845
18.
Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab.
Leuk Res
; 79: 17-21, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30797139
19.
Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience.
Leuk Res
; 81: 75-81, 2019 06.
Article
in English
| MEDLINE | ID: mdl-31054420
20.
Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: a prospective analysis.
Leuk Res
; 38(2): 170-5, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24246692